EverSource Wealth Advisors’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Other funds holding BIIB
EverSource Wealth Advisors's BIIB Position: Q2 2026 in Review
EverSource Wealth Advisors reduced its Biogen (BIIB) stake by 8.6% in Q2 2026, selling an estimated $52K and leaving 2,906 shares worth $628K. The position accounts for 0.02% of the portfolio, ranked #484.
EverSource Wealth Advisors first reported a position in BIIB in Q4 2021 and has held it in 19 quarters since. 1,045 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.
- EverSource Wealth Advisors held 2,906 shares of Biogen worth $628K as of Q2 2026.
- EverSource Wealth Advisors sold 272 Biogen shares in Q2 2026, an estimated $52K.
- Biogen made up 0.02% of EverSource Wealth Advisors's portfolio in Q2 2026, its #484 holding.
- EverSource Wealth Advisors first reported a position in Biogen in Q4 2021 and has held it in 19 quarters since.
- 1,045 funds tracked by Wall St. Rank held Biogen as of Q2 2026.
Based on EverSource Wealth Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.